CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: puromycin
Accession: CHEBI:17939
browse the term
Definition: An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.
Synonyms: exact_synonym: 3'-deoxy-N,N-dimethyl-3'-(O-methyl-L-tyrosinamido)adenosine
related_synonym: (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; 3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-diemthyladenosine; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Achromycin; Formula=C22H29N7O5; InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1; InChIKey=RXWNCPJZOCPEPQ-NVWDDTSBSA-N; SMILES=COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1; puromicina; puromycine; puromycinum
alt_id: CHEBI:14970; CHEBI:26402; CHEBI:45182; CHEBI:8641
xref: CAS:53-79-2; DrugBank:DB08437; KEGG:C01610; KEGG:D05653; KNApSAcK:C00001507; LINCS:LSM-2788
xref_mesh: MESH:D011691
xref: PMID:13945541; PMID:15843471; PMID:18322149; PMID:323854; Reaxys:70234; Wikipedia:Puromycin
cyclic_relationship: is_conjugate_base_of CHEBI:60255
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases transport affects response to substance increases expression
ISO EXP
ABCB1 protein results in increased transport of Puromycin ABCB1A protein affects the susceptibility to Puromycin Puromycin results in increased expression of ABCB1A mRNA; Puromycin results in increased expression of ABCB1A protein
CTD
PMID:14675146 PMID:20018165
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression
ISO
Puromycin results in increased expression of ABCC1 mRNA
CTD
PMID:20018165
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
Puromycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein] Puromycin inhibits the reaction [Omeprazole results in increased expression of AHR protein]; Puromycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR protein]
CTD
PMID:10777561 PMID:25797602
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
multiple interactions
EXP
Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA]
CTD
PMID:1953764
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Bax
BCL2 associated X, apoptosis regulator
affects localization
ISO
Puromycin affects the localization of BAX protein
CTD
PMID:18339127
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
Puromycin results in decreased expression of BCL2 protein Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2 protein]
CTD
PMID:21244482
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
ISO
Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein]
CTD
PMID:21244482
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Melatonin promotes the reaction [Puromycin results in increased activity of CASP3 protein]
CTD
PMID:14502240 PMID:21244482
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
ISO
Puromycin results in increased activity of CASP9 protein
CTD
PMID:14502240
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Puromycin results in decreased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
Puromycin results in decreased expression of CCL4 protein
CTD
PMID:20116850
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Cd2ap
CD2-associated protein
decreases expression
ISO
Puromycin results in decreased expression of CD2AP mRNA
CTD
PMID:15673299
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
G
Cdh3
cadherin 3
decreases expression
ISO
Puromycin results in decreased expression of CDH3 mRNA
CTD
PMID:15673299
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Ctnnb1
catenin beta 1
affects localization
ISO
Puromycin affects the localization of CTNNB1 protein
CTD
PMID:15673299
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
[Puromycin co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA Puromycin results in increased expression of CYP1A1 mRNA Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:2985607 PMID:15385644
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Def6
DEF6 guanine nucleotide exchange factor
affects localization
ISO
Puromycin affects the localization of DEF6 protein
CTD
PMID:22829599
NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961
G
Hmox1
heme oxygenase 1
increases expression
ISO
Puromycin results in increased expression of HMOX1
CTD
PMID:26260164
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il6r
interleukin 6 receptor
decreases expression
ISO
Puromycin results in decreased expression of IL6R protein modified form
CTD
PMID:20116850
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Irf1
interferon regulatory factor 1
multiple interactions
ISO
Puromycin inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein]
CTD
PMID:20525893
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Ldlr
low density lipoprotein receptor
multiple interactions decreases expression
ISO
Puromycin inhibits the reaction [GW 707 results in increased expression of LDLR mRNA]; Puromycin inhibits the reaction [Quercetin results in increased expression of LDLR mRNA]; Puromycin inhibits the reaction [Quercetin results in increased expression of LDLR protein] Puromycin results in decreased expression of LDLR mRNA; Puromycin results in decreased expression of LDLR protein
CTD
PMID:12524230 PMID:22388943
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Mir122
microRNA 122
multiple interactions
EXP
Puromycin results in decreased expression of and results in decreased secretion of MIR122 mRNA
CTD
PMID:30682439
NCBI chr18:58,758,703...58,758,787
G
Mir143
microRNA 143
multiple interactions
EXP
Puromycin results in decreased expression of and results in decreased secretion of MIR143 mRNA
CTD
PMID:30682439
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir155
microRNA 155
affects expression
EXP
Puromycin affects the expression of MIR155
CTD
PMID:30169741
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir3473
microRNA 3473
multiple interactions
EXP
Puromycin results in increased expression of and results in increased secretion of MIR3473 mRNA
CTD
PMID:30682439
NCBI chr13:39,499,246...39,499,312
Ensembl chr13:39,499,246...39,499,312
G
Nefh
neurofilament heavy chain
decreases degradation
EXP
Puromycin results in decreased degradation of NEFH mRNA
CTD
PMID:1280263
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
decreases degradation
EXP
Puromycin results in decreased degradation of NEFL mRNA
CTD
PMID:1280263
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
decreases degradation
EXP
Puromycin results in decreased degradation of NEFM mRNA
CTD
PMID:1280263
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
Puromycin inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein]
CTD
PMID:21569845
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Optn
optineurin
multiple interactions
ISO
OPTN protein affects the reaction [Puromycin results in increased secretion of VEGFA protein]
CTD
PMID:25096716
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Ptger4
prostaglandin E receptor 4
multiple interactions
ISO
[Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 protein
CTD
PMID:19643929
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of PTGER4 protein; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R protein
CTD
PMID:19643929
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Tbxa2r
thromboxane A2 receptor
multiple interactions
ISO
[Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R mRNA; [Puromycin co-treated with PTGS2 protein] results in increased expression of TBXA2R protein
CTD
PMID:19643929
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
multiple interactions
ISO
Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]
CTD
PMID:12147270
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Vegfa
vascular endothelial growth factor A
decreases expression increases secretion multiple interactions
ISO
Puromycin results in decreased expression of VEGFA protein Puromycin results in increased secretion of VEGFA protein OPTN protein affects the reaction [Puromycin results in increased secretion of VEGFA protein]
CTD
PMID:20116850 PMID:25096716
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all